SCHEMBL8312844

SCHEMBL8312844

O[C@@H]1CNCC[C@@]1(O)c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.54
HTR3A P46098 1/20 0.39
SLC6A3 Q01959 5/20 0.38
SLC6A4 P31645 4/20 0.38
SLC6A2 P23975 3/20 0.38
REN P00797 4/20 0.37
CYP3A4 P08684 4/20 0.37
KCNH2 Q12809 4/20 0.37
MAOA P21397 2/20 0.37
MAOB P27338 2/20 0.37
KDM1A O60341 1/20 0.37
PTGS2 P35354 2/20 0.36
SLC18A3 Q16572 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
AKT1 P31749 1/20 0.35
AKT2 P31751 1/20 0.35
AKT3 Q9Y243 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6095880 1.00 DRD2 (0.54) DRD2HTR3ASLC6A3SLC6A4SLC6A2
SCHEMBL652650 1.00 DRD2 (0.54) DRD2HTR3ASLC6A3SLC6A4SLC6A2
SCHEMBL15171007 1.00 DRD2 (0.54) DRD2HTR3ASLC6A3SLC6A4SLC6A2
SCHEMBL6095883 1.00 DRD2 (0.54) DRD2HTR3ASLC6A3SLC6A4SLC6A2
SCHEMBL16422778 0.83 KCNH2 (0.38) DRD2SLC6A3SLC6A4SLC6A2REN
SCHEMBL16372401 0.83 OPRM1 (0.46) RENCYP3A4KCNH2
SCHEMBL11426560 0.83 OPRM1 (0.46) RENCYP3A4KCNH2
SCHEMBL14028086 0.83 OPRM1 (0.46) RENCYP3A4KCNH2
SCHEMBL655610 0.82 DRD2 (0.53) DRD2HTR3ASLC6A3SLC6A4SLC6A2
Hydrochloric Acid SCHEMBL4614517 0.81 OPRM1 (0.44) RENCYP3A4KCNH2MAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004080460-A1 SUBSTITUTED PIPERIDINES AS NOVEL MDM2-p53 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-09-23 WO disclosed